Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.

@article{Ozasa2010LackOE,
  title={Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.},
  author={Neiko Ozasa and Takeshi Kimura and Takeshi Morimoto and Heigen Hou and Toshihiro Tamura and Satoshi Shizuta and Yoshihisa Nakagawa and Yutaka Furukawa and Yasuhiko Hayashi and Koichi Nakao and Masunori Matsuzaki and Masakiyo Nobuyoshi and Kazuaki Mitsudo},
  journal={The American journal of cardiology},
  year={2010},
  volume={106 9},
  pages={1225-33}
}
Beta-blocker therapy is recommended after ST-segment elevation acute myocardial infarction (STEMI) in current guidelines, although its efficacy in those patients who have undergone primary percutaneous coronary intervention (PCI) has not been adequately evaluated. Of 12,824 consecutive patients who underwent sirolimus-eluting stent implantation in the J-Cypher registry, we identified 910 patients who underwent PCI within 24 hours from onset of STEMI. Three-year outcomes were evaluated according… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 24 references

The effect of optimal medical therapy on 1 - year mortality after acute myocardial infarction

  • M Packer, MR Bristow, +4 authors NH Shusterman
  • Heart
  • 2010

Effect of beta blockers , particularly carvedilol , on reducing the risk of events after acute myocardial infarction

  • R Roberts, WJ Rogers, +7 authors E Passamani
  • Am J Cardiol
  • 2006

Similar Papers

Loading similar papers…